Regulatory Intelligence

The life sciences industry is ever-changing and evolving. It’s the same in the year 2018. A lot of mandatory changes have been made to the regulations, and a lot of guidance documents have been released pertaining to the best Regulatory practices of consumer healthcare, medical devices, pharmaceuticals, which are expected to impact the industry in a positive way.

As a big face lift, Health Authorities of China and South Africa have recently revealed their identifications. The China Food and Drug Administration (CFDA), has recently announced the change related to the agency’s official English name, the National Medical Product Administration (NMPA).

Wading through uncharted waters is always risky and mount numerous pressures on organizations. It not only affects organization’s financial status quo but also impose threat to brand image. If it is the same in the life sciences sector, the situation may lead to incompliance and untimely drug approvals thus posing a threat to patient safety.

About ~2500 years ago, Hippocrates, the father of medicine, welcomed the belief “Let food be thy medicine and medicine be thy food”. But with the rapid emergence of modern drug therapy, the “food as medicine” philosophy gained dust in the 19th century. Come 1900s, the primary role that diet plays to promote health and prevent diseases came to the forefront once again.